- Division of Basic and Integrative Biological Sciences – DBIB
- Review Branch:
- Basic and Translational Cancer – BTC
- Study Section:
- Basic Mechanisms in Cancer Health Disparities – BMCD
Dr. Sulagna Banerjee received her Ph.D. in life sciences from the Bose Institute, Jadavpur University, India. She then completed her post-doctoral research on glycosylation of parasitic protozoa in the Department of Molecular and Cell Biology at Boston University, MA. She went on to the University of Minnesota to study mechanisms of resistance in pancreatic and other cancers as an assistant professor at Division of Basic and Translational Research, Department of Surgery. Her research showed altered metabolic pathways in pancreatic tumor initiating cells mediate chemoresistance in this disease. Prior to joining CSR, she was an associate professor at Department of Surgery, University of Miami, FL expanding her work on therapy resistance in cancer to understand how metabolic pathways in different tumors can be exploited to sensitize them to chemo- and immune therapy. She also investigated how metabolic interaction between the tumor and its microenvironment can affect interacting signaling pathways contributing to therapy resistance.